EU competition and regulatory news
Overview of the latest EU law news
The COVID-19 effect on competition law
16 March 2020
The coronavirus pandemic is affecting people and businesses on a large and global scale, bringing major challenges for governments and companies, all of whom are trying to respond in the most responsible way possible. Although COVID-19 is a black swan for 2020, competition law continues to apply. EU Member States need to be particularly mindful of EU state aid rules, and undertakings need to maintain compliance with the applicable competition rules.
EU report reinforces competition law enforcement in the pharmaceutical industry
30 January 2019
Ten years after its pharmaceutical sector inquiry, the European Commission (“EC”) published, on 28 January 2019, a comprehensive report on pharmaceutical competition enforcement activities by both the EC and EU member states' national competition authorities (“NCAs”) in the period between 2009 to 2017 (the “Report”).
The Report provides a timely and in-depth analysis of anticompetitive practices within the pharmaceutical sector, amidst growing concerns about patients’ access to affordable and innovative medicines. These concerns have been voiced by different stakeholders, notably national health ministries and the European Parliament.